11.1 Diabetic Ketoacidosis (DKA) & Hyperosmolar Hyperglycemic State (HHS)

Diabetic Ketoacidosis (DKA) & Hyperosmolar Hyperglycemic State (HHS)

VTS Critical Concept: Diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS) represent life-threatening decompensations of diabetes mellitus. Successful management hinges on a phased resuscitation strategy: volume expansion first, electrolyte repletion second, and insulin therapy third. Administering insulin prematurely prior to fluid and potassium stabilization triggers catastrophic intravascular volume collapse, refractory hypokalemia, and cerebral edema.

---

1. Pathophysiology of DKA & Ketogenesis

Diabetic Ketoacidosis develops from a synergistic physiological failure: profound absolute or relative insulin deficiency accompanied by an excess of counter-regulatory stress hormones (glucagon, cortisol, epinephrine, and growth hormone). This hormonal imbalance creates an extreme catabolic state.

[ Absolute / Relative Insulin Deficiency + Excess Stress Hormones (Glucagon, Cortisol, Epi) ]
                                     │
         ┌───────────────────────────┴───────────────────────────┐
         ▼                                                       ▼
[ Uninhibited Lipolysis ]                               [ Hepatic Gluconeogenesis & ]
Hormone-Sensitive Lipase activated                      [ Impaired Peripheral Uptake ]
         │                                                       │
         ▼                                                       ▼
[ Free Fatty Acids (FFAs) Mobilized ]                   [ Severe Hyperglycemia ]
Carnitine Palmitoyltransferase-1 (CPT-1) activated               │
         │                                                       ▼
         ▼                                              [ Glucosuria & Osmotic Diuresis ]
[ Hepatic Mitochondrial Beta-Oxidation ]                Profound Dehydration & Shock
Acetoacetyl-CoA ──► Acetoacetate (AcAc)                         │
         │                                                       │
         ▼ (Redox Shift: High NADH/NAD+)                         │
[ Beta-Hydroxybutyrate (β-OHB) Predominance ]                    │
         │                                                       │
         └───────────────────────────┬───────────────────────────┘
                                     ▼
         [ High Anion Gap Metabolic Acidosis + Severe Electrolyte Wasting ]

The Ketogenic Pathway & Redox Shift

1. Lipolysis Activation: In the absence of insulin's inhibitory signal, adipose hormone-sensitive lipase becomes hyperactive, hydrolyzing triglycerides into glycerol and large quantities of non-esterified Free Fatty Acids (FFAs).
2. Hepatic Carnitine Palmitoyltransferase-1 (CPT-1): Elevated glucagon levels reduce hepatic malonyl-CoA concentrations, disinhibiting CPT-1. This allows rapid transport of FFAs into hepatic mitochondria for accelerated $\beta$-oxidation.
3. Ketone Body Formation: Overwhelming acetyl-CoA production exceeds the capacity of the citric acid (Krebs) cycle. Excess acetyl-CoA is shunted into ketogenesis, forming acetoacetate (AcAc), which spontaneously decarboxylates into acetone or is enzymatically reduced to $\beta$-hydroxybutyrate ($\beta$-OHB) via $\beta$-hydroxybutyrate dehydrogenase.
4. The Mitochondrial Redox State: In severe shock, tissue hypoxia and hepatic hypoperfusion cause a high mitochondrial $[\text{NADH}]/[\text{NAD}^+]$ ratio. This drives the equilibrium strongly toward $\beta$-hydroxybutyrate, making $\beta$-OHB the overwhelmingly dominant circulating ketone in acute DKA (often reaching a $\beta\text{-OHB} : \text{AcAc}$ ratio of $3:1$ to $>10:1$).

High Anion Gap Metabolic Acidosis

Acetoacetic acid and $\beta$-hydroxybutyric acid are strong organic acids that fully dissociate at physiological pH, releasing free hydrogen ions ($H^+$) and ketone anions. Circulating bicarbonate ($HCO_3^-$) buffers the excess $H^+$, causing severe metabolic acidemia and an elevated Anion Gap (AG):

$\text{Anion Gap (AG)} = ([\text{Na}^+] + [\text{K}^+]) - ([\text{Cl}^-] + [\text{HCO}_3^-])$

(Normal canine/feline AG: $12-24\text{ mEq/L}$; in acute DKA, AG frequently exceeds $28-35\text{ mEq/L}$ due to unmeasured ketoacids).

---

2. Clinical Presentation & The Diagnostic Quartet

Patients with DKA frequently have an underlying concurrent trigger that increased counter-regulatory hormones (e.g., acute pancreatitis, severe bacterial urinary tract infection, pyometra, bacterial pneumonia, Cushing's disease, or chronic kidney disease).

Clinical Signs & Physical Examination Findings

• History: Polyuria, polydipsia (PU/PD), progressive weight loss, polyphagia progressing rapidly to complete anorexia, acute vomiting, lethargy, and mental dullness.
• Kussmaul Respiration: Deep, rapid, unlabored hyperventilation without wheezes or crackles. This represents physiological respiratory compensation (blowing off arterial $CO_2$ to raise blood pH) in response to severe metabolic ketoacidosis.
• Acetone Breath Odor: A distinct sweet, fruity, or solvent-like breath odor caused by exhaled volatile acetone.
• Dehydration & Hypovolemic Shock: Dry, tacky oral mucous membranes, prolonged skin turgor, sunken orbits (enophthalmos), weak peripheral pulses, and cool extremities secondary to severe osmotic diuresis and gastrointestinal fluid loss.

The Diagnostic Quartet for DKA

The Urine Dipstick Nitroprusside Pitfall

Standard urine test strips utilize the nitroprusside reaction, which reacts strongly with acetoacetate and weakly with acetone, but possesses ZERO reactivity with $\beta$-hydroxybutyrate.

• Early False Negatives: In patients with severe shock and high $[\text{NADH}]/[\text{NAD}^+]$ redox states, almost all circulating ketones exist as $\beta$-OHB. A urine dipstick may read trace or negative for ketones despite life-threatening ketoacidosis.
• The Paradoxical 'Worsening' on Dipstick: As resuscitation restores tissue perfusion and oxygen delivery, the $[\text{NADH}]/[\text{NAD}^+]$ ratio normalizes. $\beta$-OHB is oxidized back into acetoacetate. Consequently, urine dipsticks may turn strongly positive ($4+$) after clinical improvement has begun. Point-of-care blood ketone meters directly measuring blood $\beta$-OHB are the gold standard.

---

3. Hyperosmolar Hyperglycemic State (HHS / HHNK)

Hyperosmolar Hyperglycemic State (HHS)—formerly termed Hyperosmolar Hyperglycemic Non-Ketotic Syndrome (HHNK)—is an extreme endocrine crisis characterized by massive hyperglycemia and hyperosmolality without profound ketoacidosis.

Pathophysiological Differences: DKA vs. HHS

Calculated Effective Serum Osmolality

Glucose is an effective osmole that cannot freely cross cell membranes in the absence of insulin. Osmolality draws water from the intracellular into the extracellular space, causing severe intracellular neuronal dehydration:

$\text{Effective Osmolality (mOsm/kg)} = 2 \times [\text{Na}^+\text{ (mEq/L)}] + \frac{\text{Blood Glucose (mg/dL)}}{18}$

$\text{Effective Osmolality (SI Units)} = 2 \times [\text{Na}^+\text{ (mmol/L)}] + \text{Blood Glucose (mmol/L)}$

4. Emergency Multi-Phase Resuscitation Protocol

Resuscitation of DKA must proceed in a strict, stepwise chronological sequence. Attempting to correct hyperglycemia before restoring intravascular volume and electrolyte reserves is the leading cause of iatrogenic mortality.

Phase 1: Intravascular Volume Expansion (Hours 0 to 4)

• Fluid Selection: Balanced isotonic crystalloids (Plasmalyte-148, Normosol-R, or Lactated Ringer's Solution). If severe hyponatremia is present, $0.9%\text{ NaCl}$ may be utilized.
• Fluid Deficit Calculation: $\text{Deficit Volume (mL)} = \text{Body Weight (kg)} \times \%\text{ Dehydration} \times 1000$ Administer initial shock aliquots ($10-20\text{ mL/kg}$ over $15-30\text{ min}$ in dogs; $5-10\text{ mL/kg}$ in cats) if hypovolemic shock is present. Replace the calculated deficit plus ongoing losses and maintenance over $24-48\text{ hours}$.
• CRITICAL RULE: Withhold Insulin During Phase 1:
  1. Prevention of Vascular Collapse: Intravascular volume is partially sustained by high serum hyperosmolality pulling fluid from the intracellular space. Administering insulin drives glucose into cells; water rapidly follows glucose via osmosis, causing catastrophic intravascular dehydration, acute hypotension, and cardiac arrest.
  2. Hypokalemia Prevention: Insulin drives extracellular potassium into cells. Administering insulin before establishing baseline potassium and initiating replacement precipitates lethal cardiac arrhythmias.

Phase 2: Electrolyte Repletion (Potassium & Phosphate)

Total body stores of potassium, phosphate, and magnesium are profoundly depleted in DKA due to prolonged osmotic diuresis, anorexia, and vomiting. However, initial serum bloodwork may show normal or high potassium due to extracellular shifts driven by acidemia and lack of insulin.

Potassium Supplementation Guidelines

Supplement potassium in IV fluids as soon as serum $[\text{K}^+] < 5.0\text{ mEq/L}$ and adequate urine output is confirmed. Never exceed the maximum safe peripheral IV potassium infusion rate of $0.5\text{ mEq/kg/hr}$.

Phosphate Repletion & Acute Hemolysis

• Insulin therapy drives inorganic phosphorus into cells for glucose phosphorylation.
• Severe hypophosphatemia ($[\text{PO}_4^-] < 1.5\text{ mg/dL}$ or $<0.48\text{ mmol/L}$) depletes erythrocyte adenosine triphosphate (ATP) and 2,3-diphosphoglycerate (2,3-DPG), causing red blood cell membrane rigidity, Heinz body formation, and severe, life-threatening acute intravascular hemolytic anemia, alongside diaphragmatic muscle weakness and respiratory arrest.
• Treatment: Replete $33-50%$ of calculated potassium requirements as Potassium Phosphate ($\text{KPO}_4$), with the remainder given as Potassium Chloride ($\text{KCl}$). Administer $\text{KPO}_4$ at $0.01-0.03\text{ mmol/kg/hr}$.

Phase 3: Regular Insulin Therapy & Dextrose Infusion

Initiate insulin therapy $2-4\text{ hours}$ after initiating fluid resuscitation, once hypovolemia has resolved and serum potassium is $\ge 3.5-4.0\text{ mEq/L}$.

Insulin Protocols

• Low-Dose Regular Insulin CRI (Preferred): Mix regular insulin (Humulin R, Novolin R) in $0.9%\text{ NaCl}$ (e.g., $2.2\text{ U/kg}$ in $250\text{ mL}$ saline, where $1\text{ mL/hr} = 0.01\text{ U/kg/hr}$). Note: Flush the first $50\text{ mL}$ through the IV administration set and discard, as insulin binds to plastic tubing surfaces. Initiate CRI at $0.05-0.1\text{ U/kg/hr}$.
• Intermittent Hourly Low-Dose IM Protocol: Administer an initial loading dose of Regular Insulin at $0.2\text{ U/kg IM}$, followed by $0.1\text{ U/kg IM q1h}$, monitoring blood glucose hourly.

Safe Rate of Glucose Reduction

• Target Decline: Reduce blood glucose by $50-75\text{ mg/dL/hr}$ ($2.8-4.2\text{ mmol/L/hr}$).
• Danger of Rapid Drop: Dropping blood glucose faster than $75-100\text{ mg/dL/hr}$ creates a steep osmotic gradient between the rapidly hypotonic extracellular fluid and the brain (which retains idiogenic osmoles), triggering severe cerebral edema, stupor, coma, and herniation.

Adding Dextrose to Fluids (The 200-250 mg/dL Threshold)

• When blood glucose declines to $200-250\text{ mg/dL}$ ($11.1-13.9\text{ mmol/L}$), DO NOT STOP THE INSULIN.
• Insulin is required to shut down hepatic ketogenesis, stimulate fatty acid synthesis, and clear circulating ketoacids. Stopping insulin allows ketogenesis to resume immediately.
• Action: Add dextrose to the IV crystalloids to create a $2.5%$ to $5.0%$ dextrose solution (e.g., add $50-100\text{ mL}$ of $50%$ dextrose to a $1\text{ L}$ fluid bag) and decrease the insulin CRI to $0.025-0.05\text{ U/kg/hr}$. Titrate dextrose infusion rates to maintain blood glucose between $150-250\text{ mg/dL}$ until ketonemia clears, venous pH exceeds $7.30$, $[\text{HCO}_3^-] > 18\text{ mEq/L}$, and the patient resumes voluntary eating.